Discontinued — last reported Q3 '24
Business Segments · Foreign currency translation impact
Diagnostics and Genomics — Foreign currency translation impact
Agilent Technologies Diagnostics and Genomics — Foreign currency translation impact remained flat by 0.0% to -$3.75M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 1600.0%, from $250.00K to -$3.75M.
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ3 2024
How to read this metric
A negative impact suggests a strengthening reporting currency, which can mask underlying operational growth in international markets.
Detailed definition
This represents the effect of fluctuations in exchange rates on the reported financial results of the diagnostics and ge...
Peer comparison
Standard disclosure for multinational corporations with significant operations outside their home currency jurisdiction.
Metric ID:
a_segment_diagnostics_and_genomics_foreign_currency_translation_impactHistorical Data
4 years
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $0.00 | -$11.00M | $1.00M | -$15.00M |
| YoY Change | — | — | +109.1% | <-999% |
Range-$15.00M – $1.00M
Avg YoY Growth-745.5%
Median YoY Growth-745.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's diagnostics and genomics — foreign currency translation impact?
- Agilent Technologies (A) reported diagnostics and genomics — foreign currency translation impact of -$3.75M in Q3 2024.
- How has Agilent Technologies's diagnostics and genomics — foreign currency translation impact changed year-over-year?
- Agilent Technologies's diagnostics and genomics — foreign currency translation impact decreased by 1600.0% year-over-year, from $250.00K to -$3.75M.
- What does diagnostics and genomics — foreign currency translation impact mean?
- The financial impact caused by changes in currency exchange rates on segment performance.